Clearstead Trust’s Omnicell OMCL Stock Holding History

Clearstead Trust’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-26	Closed	-$792	–	1366
2025 Q3	$792	Hold	26	–	–	﹤0.01%	1285
2025 Q2	$765	Buy	+26	New	+$778	﹤0.01%	1233

Other funds holding OMCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Clearstead Trust's OMCL Position: Q4 2025 in Review

Clearstead Trust sold out of Omnicell (OMCL) in Q4 2025, closing a stake of 26 shares — an estimated $792 sold.

Clearstead Trust first reported a position in OMCL in Q2 2025 and held it in 2 quarters. The position peaked at $792 in Q3 2025. 262 funds tracked by Wall St. Rank hold OMCL as of Q4 2025.

Clearstead Trust reported no remaining Omnicell position as of Q4 2025 after selling out during the quarter.
Clearstead Trust sold 26 Omnicell shares in Q4 2025, an estimated $792.
Clearstead Trust first reported a position in Omnicell in Q2 2025 and held it in 2 quarters.
Clearstead Trust's Omnicell position peaked at $792 in Q3 2025.
262 funds tracked by Wall St. Rank held Omnicell as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.